Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling

Paul A Clarke1, Mark L George, Sandra Easdale

  • 1Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey SM2 5NG. Paul.Clarke@icr.ac.uk

Cancer Research
|October 30, 2003
PubMed

Insights

Global gene expression profiling revealed decreased RNA, protein synthesis, and metabolism genes in rectal cancer patients during 5-fluorouracil treatment. This approach offers insights into drug mechanisms and potential combination therapies for colorectal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Understanding the precise molecular mechanisms of anticancer agents is crucial for effective treatment.
  • Global gene expression profiling offers a comprehensive approach to elucidate drug effects.
  • Existing chemotherapeutics may have unclear molecular mechanisms of action.

Purpose of the Study:

  • To investigate the feasibility and utility of global gene expression profiling in identifying cellular responses to chemotherapy.
  • To detect subtle molecular changes induced by 5-fluorouracil in rectal cancer.
  • To identify potential new therapeutic strategies for colorectal cancer based on observed gene expression patterns.

Main Methods:

  • Global gene expression profiling was performed on rectal cancer biopsies.
  • Samples were collected from patients undergoing 5-fluorouracil infusion.
  • Gene expression data was analyzed to identify significant changes in cellular pathways.

Main Results:

  • A decrease in the expression of genes involved in RNA synthesis was observed.
  • Reduced expression of genes related to protein synthesis was detected.
  • Genes essential for cellular metabolism showed decreased expression during 5-fluorouracil treatment.

Conclusions:

  • Global gene expression profiling is a feasible method for detecting chemotherapy-induced cellular responses.
  • This approach can reveal molecular effects missed by conventional methods.
  • The findings suggest novel mechanism-based combination treatments for colorectal cancer and provide insights into drug pharmacology.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...